Gene · 9739
NIH grants1,845
NIH grants whose papers are about the gene, through NIH's grant-paper links.
261 to 280 of 1,845
Download this page as JSON| Grant | Title | SETD1A papers | Newest fiscal year |
|---|---|---|---|
| R35GM122480 | Proteomics and model organism humanization to decode human genetics | 1 | 2025 |
| R35GM122506 | Exploring New Players in Proteostasis | 1 | 2025 |
| R35GM124780 | Investigating the impact of genetic variation on the ER stress response, protein folding, and disease | 1 | 2025 |
| R35GM124958 | Chromatin Dynamics and Genome Regulation | 1 | 2025 |
| R35GM127034 | Structural studies of chromatin complexes | 1 | 2025 |
| R35GM128840 | Discovering and Exploiting Selectivity within Tandem Bromodomains | 1 | 2025 |
| R35GM128947 | Single-cell analysis and synthetic control of mammalian chromatin dynamics and gene regulation | 1 | 2025 |
| R35GM133441 | Investigating chromatin mechanisms using viral systems | 1 | 2025 |
| R35GM133732 | Chromatin-mediated mechanisms of transcription regulation in ES cells | 1 | 2025 |
| R35GM134919 | New methods for computational modeling of RNA structures | 1 | 2025 |
| R35GM139816 | Novel pathways that regulate DNA double-strand break repair events in mammalian cells | 1 | 2025 |
| R35GM142679 | Chromatin Regulation of Tissue Regeneration and Stem Cell Function | 1 | 2025 |
| R35GM143532 | Site-specific control of human gene regulation for therapeutically applicable mechanistic insights | 1 | 2025 |
| R35GM144131 | Deciphering Networks Controlling DNA Amplification | 1 | 2025 |
| R35GM151089 | Multi-modal insights of spatially distributed cells with associations of diseases and drug response | 1 | 2025 |
| R35NS127083 | Contribution of Myeloid-Derived Suppressor Cells to Neuro-Inflammatory Alterations and Disease Progression in Glioblastoma | 1 | 2025 |
| R37CA230617 | Hormone signaling and translation control in advanced prostate cancer | 1 | 2025 |
| R37CA233691 | Combinational Targeting the Feed-forward Epigenetic Circuitry in Mixed Lineage Leukemia | 1 | 2025 |
| R37CA234021 | Developing and credentialing patient-derived xenograft models to advance therapeutic approaches for chronic myelomonocytic leukemia | 1 | 2025 |
| R37CA249007 | Engrailed-1 and Epigenetic Vulnerabilities in Metastatic Pancreatic Cancer | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9739/grants?page=14